Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06QZL
|
||||
| Former ID |
DCL000864
|
||||
| Drug Name |
Lerisetron
|
||||
| Synonyms |
Lerisetron[inn]; 1-benzyl-2-piperazin-1-ylbenzimidazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Nausea; Vomiting; Testicular germ cell tumor; Emesis [ICD9: 140-199, 183, 186, 210-229, 220, 222.0, 787, 787.0; ICD10:C00-C75, C56, C62, C7A, C7B, D10-D36, D27, D29.2, D3A, R11] | Phase 3 | [536188] | ||
| Company |
FAES Farma
|
||||
| Formula |
C18H20N4
|
||||
| Canonical SMILES |
C1CN(CCN1)C2=NC3=CC=CC=C3N2CC4=CC=CC=C4
|
||||
| InChI |
1S/C18H20N4/c1-2-6-15(7-3-1)14-22-17-9-5-4-8-16(17)20-18(22)21-12-10-19-11-13-21/h1-9,19H,10-14H2
|
||||
| InChIKey |
PWWDCRQZITYKDV-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 143257-98-1
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-Hydroxytryptamine 3 receptor | Target Info | Antagonist | [536188] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.